In the News

105 News Items found
Kate Delp standing on the beach, smiling and holding a yoga mat
Finding
An MSK study found a rise in lumpectomies and a decline in mastectomies — reversing a trend that experts say was leading to the overtreatment of breast cancer.
Albert Kuchler discussing his treatment results with MSK oncologist Bob Li at a recent clinic visit.
Feature
The drug targets a protein called HER2 found on some salivary gland tumors.
Nurses from the David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
Meet the winners of the 2022 Robbins Family Awards for Excellence at Memorial Sloan Kettering Cancer Center.
Sienna plays with toys on a hospital bed
Learn how 4-year-old Sienna, her family, and the people of MSK Kids inspire each other to continue improving treatments for all children with cancer.
Albert Kuchler with MSK medical oncologist Bob Li.
Computational biology is helping to bring predictive power and precision to oncology.
Kirt Robinson
In the Clinic
A clinical trial led by MSK sarcoma expert Mrinal Gounder has shown promising results for treating desmoid tumors.
MSK has joined with 68 of the nation’s top cancer centers in issuing a statement urging increased HPV vaccination for the prevention of cancer. This statement, signed by MSK Physician-in-Chief and Chief Medical Officer José Baslega, MD, PhD, and colleagues at NCI-designated cancer centers across the country, calls upon the nation’s physicians, parents, and young adults to take advantage of this rare opportunity to prevent many types of cancer. MSK head and neck and gynecologic cancer experts are available to discuss the importance of the HPV vaccine and risks of HPV-related cancers. Please email [email protected] to arrange an interview.
Clinical nurse Jenna Longo, neuroendocrinologist Eliza Geer, neurosurgeon Viviane Tabar, and head and neck surgeon Marc Cohen
In the Clinic
Learn what sets care for pituitary tumors apart from the rest at Memorial Sloan Kettering’s Multidisciplinary Pituitary and Skull Base Tumor Center.
The US Food and Drug Administration has updated its recommendations for the use of Gardasil 9, the vaccine that protects against human papillomavirus (HPV), to include people age 27 to 45. Previously, Gardasil 9 was only approved for use in those between age nine and 26. 
Doctor putting a band-aid on a girl's arm
In the Clinic
3 Things to Know about Cervical Cancer
Learn from gynecologic surgeon Vance Broach about cervical cancer prevention, diagnosis, and treatment.